Evidence map›Paper›PMID 21345697›Full record

ArticleBiologicals : journal of the International Association of Biological Standardization2011

Development of a real-time reverse-transcription-PCR method for detection of RD114 virus in canine vaccines.

Rie Narushima, Tomoaki Shimazaki, Toshio Takahashi

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Biologicals : journal of the International Association of Biological Standardization, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rie NarushimaNational Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1 Tokura, Kokubunji, Tokyo 185-8511, Japan. narusima@nval.maff.go.jp
Tomoaki Shimazaki
Toshio Takahashi
Ministry of Agriculture, Forestry and Fisheries · JPNippon Veterinary and Life Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that certain feline cell lines, such as the Crandell-Rees feline kidney cell, produce an RD-114-like virus. As a feline endogenous retrovirus, RD114 virus, exists in the genome of all cats, it can be assumed that contamination with the virus in feline and canine live vaccines manufactured by culturing cells of feline origin occurs. To detect an infectious RD114 virus in vitro, a LacZ marker rescue assay has recently been established. In feline and canine live vaccines approved in Japan, feline cell lines are widely used to produce vaccines, especially those containing canine parvovirus components. The LacZ marker rescue assay detects infectious viral particles, but the real-time reverse-transcription-PCR detects both infectious and defective viruses. The canine live vaccines manufactured in cells of feline origin showed positive results for the env gene by the real-time reverse-transcription-PCR, including all of the 8 vaccines produced in feline cell lines that were negative in the LacZ marker rescue assay. In conclusion, the present investigation suggests that the newly developed method has the advantages of shorter time requirements and can be applied as a valuable screening method to detect RD114 viral RNA in vaccines.

Indexed as

AnimalsCat DiseasesCatsCells, CulturedDog DiseasesDogsEndogenous RetrovirusesMinkReverse Transcriptase Polymerase Chain ReactionRNA, ViralSensitivity and SpecificityViral VaccinesVirus DiseasesRNA, ViralViral Vaccines

Identifiers

PMID21345697
PMCPMC7129332
OpenAlexW2028911952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.